AFP and hepatocellular carcinoma: Stratifying the cohort to isolate BCLC-C disease revealed that the HCC burden was well controlled between BCLC stages but was accompanied by a higher AFP at diagnosis in BCLC-C patients (median AFP 598 vs. 41 ng/mL) (Table 5).